Diabetics use glucose monitors. Should non-diabetics use them too?
Not everyone in the health field is so bullish on the prospects of CGMs for everyone, and question whether digging in too ...
health.economictimes.indiatimes18h
Abbott bumps up profit forecast on strong medical device sales
Increasing diabetes care awareness, wider insurance coverage and preference for devices that do not need finger pricks have ...
Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor
Senseonics Holdings, Inc. (NYSE American: SENS) ("Senseonics" or the "Company"), a medical technology company focused on the ...
Click2Houston6d
‘We love this fairly low-risk intervention’: Over-the-counter device is helping people gain insight into their health
Continuous glucose monitors (CGM), once exclusive to diabetics, are now available over-the-counter, opening new possibilities ...
Abbott1d
Strong Performance by Abbott’s Base Business Drives Q3 Earnings
Abbott’s earnings for the third quarter (Q3) of 2024 saw global sales reach $10.6 billion, a strong performance driven by the ...
Glucose monitors for diabetes have finally been funded – but there's a problem
There are problems within the health system that mean full patient access to training on how to use the insulin pumps will ...
Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...
Investing6d
Eversense 365 CGM system launches for year-long diabetes monitoring
This boost aligns with the FDA's approval of Senseonics' Eversense 365-day continuous glucose monitoring system (CGM) with iCGM status, a significant milestone for the company. Analysts from ...
Glucose monitors for diabetes have finally been funded – but a chronic workforce shortage will limit the benefits
To meet international guidelines, New Zealand needs to double the workforce that supports people with diabetes. Unless that ...
Is Abbott Laboratories Stock a Buy?
If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...